TMCI has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
TMCI has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Treace Medical Concepts's interest expense for the three months ended in Sep. 2024 was $ -1.3 Mil. Its interest expense for the trailing twelve months (TTM) ended in Sep. 2024 was $-5.2 Mil.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Treace Medical Concepts's Operating Income for the three months ended in Sep. 2024 was $ -15.1 Mil. Treace Medical Concepts's Interest Expense for the three months ended in Sep. 2024 was $ -1.3 Mil. Treace Medical Concepts did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.
The historical data trend for Treace Medical Concepts's Interest Expense can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Treace Medical Concepts Annual Data | |||||||||||
Trend | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | ||||||
Interest Expense | -0.84 | -4.52 | -4.06 | -4.40 | -5.17 |
Treace Medical Concepts Quarterly Data | ||||||||||||||||||||
Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | |
Interest Expense | Get a 7-Day Free Trial | -1.30 | -1.30 | -1.32 | -1.31 | -1.31 |
Interest Expense is the amount reported by a company or individual as an expense for borrowed money.
Interest Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-5.2 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Treace Medical Concepts (NAS:TMCI) Interest Expense Explanation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.
Treace Medical Concepts's Interest Expense for the three months ended in Sep. 2024 was $-1.3 Mil. Its Operating Income for the three months ended in Sep. 2024 was $-15.1 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Sep. 2024 was $69.7 Mil.
Treace Medical Concepts's Interest Coverage for the quarter that ended in Sep. 2024 is calculated as
Treace Medical Concepts did not have earnings to cover the interest expense. |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The higher the ratio, the stronger the company's financial strength is.
John T. Treace | director, 10 percent owner, officer: Chief Executive Officer | C/O TREACE MEDICAL CONCEPTS, INC., 203 FORT WADE ROAD, SUITE 150, PONTE VEDRA FL 32081 |
James T Treace | director | 117 BRISTOL PLACE, PONTE VEDRA BEACH FL 32082 |
Richard W Mott | director | 1221 CROSSMAN AVENUE, SUNNYVALE CA 94089 |
Jane E Kiernan | director | 525 W ROSCOE, CHICAGO IL 60657 |
Deepti Jain | director | 3701 WAYZATA BLVD, MINNEAPOLIS MN 55416 |
John K Bakewell | director | C/O LANTHEUS MEDICAL IMAGING, INC., 331 TREBLE COVE ROAD, NO. BILLERICA MA 01862 |
F Barry Bays | director | |
Betsy Hanna | director | C/O TREACE MEDICAL CONCEPTS, INC., 203 FORT WADE RD #150, PONTE VEDRA BEACH FL 32081 |
Sean F. Scanlan | officer: See Remarks | C/O TREACE MEDICAL CONCEPTS, INC., 203 FORT WADE ROAD, SUITE 150, PONTE VEDRA FL 32081 |
Thomas E Timbie | director | |
Daniel E. Owens | officer: Chief HR Officer | C/O TREACE MEDICAL CONCEPTS, INC., 203 FORT WADE ROAD, SUITE 150, PONTE VEDRA FL 32081 |
Aaron Berutti | officer: Sr. VP, Sales | C/O TREACE MEDICAL CONCEPTS, INC., 203 FORT WADE ROAD, SUITE 150, PONTE VEDRA FL 32081 |
Scot Michael Elder | officer: *See "Remarks" | C/O TREACE MEDICAL CONCEPTS, INC., 203 FORT WADE ROAD, SUITE 150, PONTE VEDRA FL 32081 |
Mark Hair | officer: Chief Financial Officer | C/O RESTORATION ROBOTICS, INC., 128 BAYTECH DRIVE, SAN JOSE CA 95134 |
Lance A Berry | director | 5677 AIRLINE ROAD, ARLINGTON TN 38002 |
From GuruFocus
By PRNewswire • 11-04-2024
By Business Wire • 10-31-2024
By PRNewswire • 11-12-2024
By Marketwired • 11-04-2024
By PRNewswire • 10-28-2024
By GuruFocus News • 10-09-2024
By Marketwired • 12-02-2024
By GuruFocus News • 11-09-2024
By GlobeNewswire • 11-04-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.